The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
Argitaratua izan da: | BMC Anesthesiology 22(2022)S. 12 |
---|---|
Egile Nagusiak: | Unterberg, Matthias (Egilea), Rahmel, Tim (Egilea), Köhler, Thomas (Egilea), Henzler, Dietrich (Egilea), Schwier, Elke (Egilea) |
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
2022
|
Gaiak: | |
Sarrera elektronikoa: | https://doi.org/10.1186/s12871-021-01547-8 |
Antzeko dokumentuak: | In:
BMC Anesthesiology |
Antzeko izenburuak
-
Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
nork: Kirchner, Carmen, et al.
Argitaratua: (2019) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
nork: Köhler, Thomas, et al.
Argitaratua: (2021) -
Interrupted Chain of Transmission in a Pediatric COVID-19 Case
nork: Grautoff, Steffen
Argitaratua: (2020) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
nork: Köhler, Thomas, et al.
Argitaratua: (2022) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
nork: Schwier, Elke, et al.
Argitaratua: (2021)